MUC1 and neoplasm: To date, several tumor-specific carbohydrates were increased by different degrees and have been found be associated with breast cancer and have been used in tumor therapy as targeted antigens, such as Tn antigen, sialyl Lewis X antigen, MUC1 glycoprotein, Her-2/Neu glycoprotein and CEA [41].